Cargando…

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

BACKGROUND: Antimicrobial activity of tigecycline and comparator agents was assessedin vitroagainst 27857 isolates source from blood samples collected between 2012 and 2016 as part of the Tigecycline Evaluation and Surveillance Trial (TEST). METHODS: The broth microdilution methods was used to deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhijie, Chen, Meng, Yu, Ying, Pan, Sisi, Liu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293588/ https://www.ncbi.nlm.nih.gov/pubmed/30564308 http://dx.doi.org/10.1186/s13756-018-0441-y

Ejemplares similares

Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
por: Stefani, Stefania, et al.
Publicado: (2016)

The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016
por: Decousser, Jean-Winoc, et al.
Publicado: (2018)

Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011
por: Stefani, Stefania, et al.
Publicado: (2013)

Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial
por: Vega, Silvio, et al.
Publicado: (2017)

Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
por: Denys, Gerald A, et al.
Publicado: (2013)

Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Giammanco, Anna, et al.
Publicado: (2017)

Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST)
por: Zhang, Zhijie, et al.
Publicado: (2019)

Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline
por: Babaei, Sima, et al.
Publicado: (2021)

Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010
por: Fernández-Canigia, Liliana, et al.
Publicado: (2012)

A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012
por: Cattoir, Vincent, et al.
Publicado: (2014)

A7.5 In Vitro antibacterial activity against Gram-positive and Gram-negative pathogens in Asia - Tigecycline evaluation surveillance trial (T.E.S.T.)
Publicado: (2005)

Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
por: Mabrouk, Samar S., et al.
Publicado: (2023)

Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU
por: Moise, Pamela A, et al.
Publicado: (2021)

Novel Antimicrobial Agents for Gram-Negative Pathogens
por: Karvouniaris, Marios, et al.
Publicado: (2023)

In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program
por: Shortridge, Dee, et al.
Publicado: (2022)

Antimicrobial Activity of Trifoliate Orange (Poncirus trifoliate) Seed Extracts on Gram-Negative Food-borne Pathogens
por: Kim, Seong Yeong, et al.
Publicado: (2012)

Determining the Risk of Antimicrobial Resistance in Common Gram-Positive and Gram-Negative Pathogens After Antibiotic Exposure
por: Hudson, Nicholas, et al.
Publicado: (2015)

High dose of tigecycline for extremely resistant Gram-negative pneumonia: yes, we can
por: Garnacho-Montero, José, et al.
Publicado: (2014)

Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria
por: Deng, Tian, et al.
Publicado: (2022)

New Disturbing Trend in Antimicrobial Resistance of Gram-Negative Pathogens
por: Lee, Jung Hun, et al.
Publicado: (2009)

Antimicrobial susceptibility of Gram-negative uropathogens isolated from obstetric patients.
por: Jamie, Whitney E, et al.
Publicado: (2002)

Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins
por: Hashemi, Marjan M., et al.
Publicado: (2017)

86. Access to Antimicrobial Susceptibility Testing for Novel Gram-Negative Antibiotics
por: Lee, Yuman, et al.
Publicado: (2021)

In Vitro Activity of Omadacycline and Comparator Compounds Against Gram-positive Isolates Collected in the USA During 2016 as Part of a Global Surveillance Program
por: Huband, Michael D, et al.
Publicado: (2017)

Efficacy and Safety of Colistin versus Tigecycline for Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens—A Meta-Analysis
por: Abushanab, Dina, et al.
Publicado: (2022)

143. Correlation Between Identification of Gram-positive Resistance Genes and Antimicrobial Susceptibility Profiles in Gram Positive Bacteria
por: Ilyas, Sahrish, et al.
Publicado: (2023)

Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system
por: Ullberg, Måns, et al.
Publicado: (2019)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

Tigecycline Susceptibility Trends Among Pathogens Isolated from Complicated Skin and Soft-Tissue Infections in North and Latin America: 2012–2016
por: Hoban, Daryl, et al.
Publicado: (2017)

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens
por: Lee, Ching-Yu, et al.
Publicado: (2011)

Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens
por: Shah, Parth N., et al.
Publicado: (2018)

Metallohelices that kill Gram-negative pathogens using intracellular antimicrobial peptide pathways
por: Simpson, Daniel H., et al.
Publicado: (2019)

Mechanisms of antimicrobial resistance in Gram-negative bacilli
por: Ruppé, Étienne, et al.
Publicado: (2015)

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST
por: Anton-Vazquez, Vanesa, et al.
Publicado: (2019)

Antimicrobial activity of ceftobiprole and comparator agents when tested against gram-positive and -negative organisms collected across China (2016–2018)
por: Dandan, Yin, et al.
Publicado: (2022)

Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients
por: Ashour, Hossam M, et al.
Publicado: (2009)

In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project
por: Schnall, Jesse, et al.
Publicado: (2019)

Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008)
por: Tomic, Viktorija, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tc7hnjo5mgu1ls0kdhe2d3b95d